Search
Glumetinib
go.drugbank.com/drugs/DB15630InvestigationalGlumetinib is under investigation in clinical trial NCT04270591 (Assess the Anti-tumor Activity and Safety of Glumetinib in Patient With Advanced C-met-positive Non-small Cell Lung Cancer).
AMP-201
go.drugbank.com/drugs/DB18663ExperimentalIt is under investigation for the treatment of collagen Q congenital myasthenia.
Human Amniotic Fluid
go.drugbank.com/drugs/DB15871InvestigationalHuman amniotic fluid is the liquid surrounding the human embryo and fetus. Physically, the fluid provides protection through cushioning. Chemically, the fluid provides protection through its inherent antibacterial properties. The fluid c...
Ulotaront
go.drugbank.com/drugs/DB15665Investigational[A193506] SEP-363856 was developed by Sunovion pharmaceuticals. … [L12891] An initial clinical study has shown this drug may be effective against both positive and negative symptoms of schizophrenia.
AZD 3355
go.drugbank.com/drugs/DB05404InvestigationalIt is developed by AstraZeneca and is currently in phase I/II trials.
Dimethylcurcumin
go.drugbank.com/drugs/DB06133InvestigationalIt is a novel anti-androgen that enhances androgen receptor degradation.
NOP-1A
go.drugbank.com/drugs/DB15208InvestigationalNOP-1A is under investigation in clinical trial NCT01198197 (PET Brain and Whole Body Distribution Studies for Nociceptin/Orphanin FQ Peptide (NOP) Receptor Using [11C]NOP-1A).
Reloxiliase
go.drugbank.com/drugs/DB17653ExperimentalIt is being investigated for the treatment of hyperoxaluria.[A258823]
WP-1301
go.drugbank.com/drugs/DB17702ExperimentalIt binds to an MHC class II molecule and is recognized by a Factor VIII-specific T cell.[L46138]